共 8 条
[1]
The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The New England Journal of Medicine . 1990
[2]
Primary prevention of atrial thromboembolism in nonrheumatic atrial fibrillation in primary care: randomized controlled trial comparing two intensities of coumarin with aspirin. Hellemons BSP,Langenberg M,Lodder J,et al. British Medical Journal . 1999
[3]
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Benavente O,Hart R,Koudstaal P,et al. Cochrane Library . 2003
[4]
Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group. The New England Journal of Medicine . 1995
[5]
Stroke prevention in atrial fibrillation study (final results). Stroke Prevention in Atrial Fibrillation Investigators. Circulation . 1991
[6]
Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. Vittorio P,Antonella F,Fabio B,et al. The American Journal of Cardiology . 1998
[7]
Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Michael DE,Samuel LB. The New England Journal of Medicine . 1992
[8]
Duration of treatment with vitamin K antagonists in symrptomatic venous thromboembolism. Hutten BA,Prins MH. Cochrane Library . 2003